#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16198	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2478	802.8	0	.	n	.	0	A69G	SNP	69	69	A	497	497	G	1068	G,A,T,C	784,280,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16198	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2478	802.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1878	1878	T	1028	T,G,A,C	1021,3,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16198	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2478	802.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1612	1612	C	1017	C,G	1016,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28584	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4111	866.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1974	1974	A	1161	A,G	1159,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28584	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4111	866.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2608	2608	C	1036	C,G	1035,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28584	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4111	866.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2682	2682	A	981	A	980	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28584	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4111	866.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3234	3234	C	1003	C,T,G,A	999,1,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	2340	folP	852	852	99.88	folP.l15.c30.ctg.1	1930	150.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	969	971	AAA	246;246;244	A;A;A	246;246;244	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	2340	folP	852	852	99.88	folP.l15.c30.ctg.1	1930	150.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1200	1202	AGC	246;244;248	A,T;G;C	245,1;244;248	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5478	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3960	172.5	1	SNP	p	S91F	0	.	.	271	273	TCC	885	887	TCC	172;169;170	T;C,T;C	172;168,1;170	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5478	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3960	172.5	1	SNP	p	D95G	0	.	.	283	285	GAC	897	899	GAC	176;177;177	G;A;C	176;177;177	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5478	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3960	172.5	1	SNP	p	D95N	0	.	.	283	285	GAC	897	899	GAC	176;177;177	G;A;C	176;177;177	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2094	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1832	142.3	1	SNP	p	G45D	0	.	.	133	135	GGC	726	728	GGC	243;239;237	G;G,T;C	243;238,1;237	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1154	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1607	89.6	0	.	n	.	0	A197.	DEL	197	197	A	858	858	A	222	A	222	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	6032	parC	2304	2304	99.91	parC.l15.c17.ctg.1	3284	228.3	1	SNP	p	D86N	0	.	.	256	258	GAC	746	748	GAC	309;308;307	G;A,T;C,A	309;307,1;306,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	6032	parC	2304	2304	99.91	parC.l15.c17.ctg.1	3284	228.3	1	SNP	p	S87W	0	.	.	259	261	AGT	749	751	AGT	306;305;303	A;G,T,C;T,A	306;303,1,1;302,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	6032	parC	2304	2304	99.91	parC.l15.c17.ctg.1	3284	228.3	1	SNP	p	S87R	0	.	.	259	261	AGT	749	751	AGT	306;305;303	A;G,T,C;T,A	306;303,1,1;302,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	6032	parC	2304	2304	99.91	parC.l15.c17.ctg.1	3284	228.3	1	SNP	p	S87I	0	.	.	259	261	AGT	749	751	AGT	306;305;303	A;G,T,C;T,A	306;303,1,1;302,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	6032	parC	2304	2304	99.91	parC.l15.c17.ctg.1	3284	228.3	1	SNP	p	S88P	0	.	.	262	264	TCC	752	754	TCC	306;307;308	T,C;C,T,A;C	305,1;305,1,1;308	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4568	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3046	186.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1769	1771	GGC	260;259;258	G,T,A;G;C	258,1,1;259;258	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4238	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2870	184.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1519	1521	GCA	233;237;241	G;C;A	232;236;240	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4238	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2870	184.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1522	1524	ATC	237;237;237	A;T;C	236;236;237	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4238	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2870	184.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1534	1536	GTG	230;231;228	G;T,G;G,T	230;229,1;226,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4238	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2870	184.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1534	1536	GTG	230;231;228	G;T,G;G,T	230;229,1;226,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4238	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2870	184.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2038	2040	ACC	236;234;236	A;C;C,T	236;234;235,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4238	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2870	184.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2092	2094	GCG	222;223;221	G;C,G;G	222;222,1;221	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4238	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2870	184.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2092	2094	GCG	222;223;221	G;C,G;G	222;222,1;221	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4238	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2870	184.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2215	2217	GGC	231;227;227	G;G;C,G	231;227;226,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4238	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2870	184.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2224	2226	GGC	231;234;237	G,C;G;C,A	230,1;234;235,2	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4238	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2870	184.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2242	2244	CTG	227;229;229	C;T,C;G	227;228,1;229	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6308	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3513	223.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1802	1804	CCG	251;254;259	C;C,A;G	251;253,1;259	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2746	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2354	145.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	812	812	C	205	C	205	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	320	porB1a	984	154	92.86	porB1a.l15.c17.ctg.3	154	55.4	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	33;35;36	T;T;A	33;35;36	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	320	porB1a	984	154	92.86	porB1a.l15.c17.ctg.3	154	55.4	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	68;68;68	C;A;T	68;68;68	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	320	porB1a	984	154	92.86	porB1a.l15.c17.ctg.3	154	55.4	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	68;68;68	A;G;T	68;68;68	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	320	porB1a	984	154	92.86	porB1a.l15.c17.ctg.3	154	55.4	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	68;68;68	T;A;C	68;68;68	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3414	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1571	256.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	503	505	GAA	294;292;293	G,T;A,C;A	293,1;291,1;293	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3414	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1571	256.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	791	793	GAT	283;285;289	G,A,C;A,C;T,A	280,2,1;283,1;287,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3414	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1571	256.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	914	916	TCA	307;304;303	T,G;C;A	306,1;304;303	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3414	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1571	256.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1043	1045	GTC	295;297;298	G;T;C	295;297;298	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3414	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1571	256.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1373	1375	GCA	275;278;278	G;C,T;A,C	275;277,1;276,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3414	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1571	256.2	1	SNP	p	G120K	1	.	.	358	360	AAG	749	751	AAG	268;270;267	A;A;G,A	268;270;266,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3414	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1571	256.2	1	SNP	p	D121N	0	.	.	361	363	GAC	752	754	GAC	268;272;270	G;A;C,G	268;272;269,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3414	porB1b	1047	1047	99.33	porB1b.l15.c30.ctg.1	1571	256.2	1	SNP	p	A121D	1	.	.	361	363	GAC	752	754	GAC	268;272;270	G;A;C,G	268;272;269,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11234	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5327	262.9	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2233	2235	AAT	275;277;277	A,G,T;A;T	272,1,2;277;277	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1666	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1438	144.4	1	SNP	p	V57M	1	.	.	169	171	ATG	726	728	ATG	317;319;320	A;T;G	317;319;320	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
